Literature DB >> 7000307

Quantitative microhaemagglutination assay for Treponema pallidum antibodies in experimental syphilis.

R R Tight, A C White.   

Abstract

The quantitative microhaemagglutination assay for Treponema pallidum antibodies (MHA-TP) was studies in 52 untreated and treated rabbits with experimental syphilis. Rabbits with incubating experimental syphilis were cured or inadequately treated with penicillin G and some cured rabbits were later reinfected. MHA-TP conversion occurred within 45 days in untreated rabbits. Titres reached peak levels about four months after inoculation and remained relatively high for up to two years. The quantitative MHA-TP test differentiated between rabbits cured of experimental incubating syphilis and those untreated and inadequately treated. MHA-TP titres decreased after treatment given six or 12 months after inoculation but reversion did not occur. MHA-TP conversion or significant increases in titre occurred as soon as seven days after reinfection and preceded corresponding changes in a quantitative non-treponemal test. The MHA-TP is useful as a screening test for treponemal antibodies in rabbits. The quantitative MHA-TP in humans after treatment for syphilis and reinfection deserves further study.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7000307      PMCID: PMC1045808          DOI: 10.1136/sti.56.5.291

Source DB:  PubMed          Journal:  Br J Vener Dis        ISSN: 0007-134X


  15 in total

1.  Effect of spectinomycin on T. pallidum in incubating experimental syphilis.

Authors:  D Petzoldt
Journal:  Br J Vener Dis       Date:  1975-10

2.  Treponema pallidum haemagglutination assay in the routine serodiagnosis of treponemal disease.

Authors:  P O'Neill; R W Warner; C S Nicol
Journal:  Br J Vener Dis       Date:  1973-10

3.  Evaluation of a quantitative automated micro-hemagglutination assay for antibodies to Treponema pallidum.

Authors:  L C Logan; P M Cox
Journal:  Am J Clin Pathol       Date:  1970-02       Impact factor: 2.493

4.  Comparison of the VDRL slide, TPI, and FTA-ABS tests in experimental syphilis in rabbits.

Authors:  S M Mothershed; A R Yobs; J W Clark
Journal:  Br J Vener Dis       Date:  1967-12

5.  Experimental rabbit syphilis.

Authors:  P Collart; P Franceschini; P Durel
Journal:  Br J Vener Dis       Date:  1971-12

6.  Therapy for incubating syphilis. Effectiveness of gonorrhea treatment.

Authors:  A L Schroeter; R H Turner; J B Lucas; W J Brown
Journal:  JAMA       Date:  1971-11-01       Impact factor: 56.272

7.  Studies on Treponema pallidum haemagglutination antibodies. I. TPHA antibodies in experimental syphilitic rabbits.

Authors:  S Okamoto; Y Tanabe
Journal:  Br J Vener Dis       Date:  1971-04

8.  Incidence of reactive VDRL tests in the normal rabbit.

Authors:  J S Pannu; M A Rosenberg; C W Israel; J L Smith
Journal:  Br J Vener Dis       Date:  1967-06

9.  Evaluation of the qualitative and automated quantitative microhemagglutination assay for antibodies to Treponema pallidum.

Authors:  E M Coffey; L L Bradford; L S Naritomi; R M Wood
Journal:  Appl Microbiol       Date:  1972-07

10.  Automated, quantitative microhemagglutination assay for Treponema pallidum antibodies.

Authors:  P M Cox; L C Logan; L C Norins
Journal:  Appl Microbiol       Date:  1969-09
View more
  9 in total

1.  Chronicity of infection with Treponema paraluis-cuniculi in New Zealand white rabbits.

Authors:  R F DiGiacomo; S A Lukehart; C D Talburt; S A Baker-Zander; W E Giddens; J Condon; C W Brown
Journal:  Genitourin Med       Date:  1985-06

2.  Quantitative microhaemagglutination assay for Treponema pallidum antibodies in humans.

Authors:  H Young; J M Hunter
Journal:  Br J Vener Dis       Date:  1981-04

3.  Murine monoclonal antibodies specific for virulent Treponema pallidum (Nichols).

Authors:  S M Robertson; J R Kettman; J N Miller; M V Norgard
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

4.  Monoclonal antibody analysis of specific antigenic similarities among pathogenic Treponema pallidum subspecies.

Authors:  K S Marchitto; S A Jones; R F Schell; P L Holmans; M V Norgard
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

5.  Molecular specificities of monoclonal antibodies directed against virulent Treponema pallidum.

Authors:  K S Marchitto; C K Selland-Grossling; M V Norgard
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

6.  Evaluation of Sch 29482 in experimental syphilis and comparison with penicillin G benzathine in disseminated disease and localized infection.

Authors:  R E Baughn; C Adams; D M Musher
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

7.  Ig class and IgG subclass responses to Treponema pallidum in patients with syphilis.

Authors:  R E Baughn; J L Jorizzo; C B Adams; D M Musher
Journal:  J Clin Immunol       Date:  1988-03       Impact factor: 8.317

8.  Sensitivity and specificity of monoclonal antibodies directed against antigenic determinants of Treponema pallidum Nichols in the diagnosis of syphilis.

Authors:  M V Norgard; C K Selland; J R Kettman; J N Miller
Journal:  J Clin Microbiol       Date:  1984-10       Impact factor: 5.948

9.  Monoclonal antibody with hemagglutination, immobilization, and neutralization activities defines an immunodominant, 47,000 mol wt, surface-exposed immunogen of Treponema pallidum (Nichols).

Authors:  S A Jones; K S Marchitto; J N Miller; M V Norgard
Journal:  J Exp Med       Date:  1984-11-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.